The investment seeks to maximize capital appreciation... Show more
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Category MidCapBlend
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| FBT | 211.17 | 1.19 | +0.57% |
| First Trust NYSE Arca Biotech ETF | |||
| BLGR | 29.31 | 0.14 | +0.49% |
| Bluemonte Large Cap Growth ETF | |||
| EMF | 17.04 | 0.04 | +0.24% |
| Templeton Emerging Markets Fund | |||
| NEWZ | 27.52 | 0.02 | +0.07% |
| EA Series Trust StockSnips AI-Powered Sentiment US All Cap ETF | |||
| RSF | 14.40 | -0.04 | -0.28% |
| RiverNorth Capital and Income Fund | |||
A.I.dvisor indicates that over the last year, DNLYX has been closely correlated with VMCPX. These tickers have moved in lockstep 92% of the time. This A.I.-generated data suggests there is a high statistical probability that if DNLYX jumps, then VMCPX could also see price increases.
| Ticker / NAME | Correlation To DNLYX | 1D Price Change % | ||
|---|---|---|---|---|
| DNLYX | 100% | N/A | ||
| VMCPX - DNLYX | 92% Closely correlated | N/A | ||
| VIMAX - DNLYX | 92% Closely correlated | N/A | ||
| VIMSX - DNLYX | 92% Closely correlated | N/A | ||
| VMCIX - DNLYX | 92% Closely correlated | N/A | ||
| FSMDX - DNLYX | 92% Closely correlated | N/A | ||
More | ||||